Sustained antiviral response against in vitro HIV-1 infection in peripheral blood mononuclear cells from people with chronic myeloid leukemia treated with ponatinib.
Saved in:
| Title: | Sustained antiviral response against in vitro HIV-1 infection in peripheral blood mononuclear cells from people with chronic myeloid leukemia treated with ponatinib. |
|---|---|
| Authors: | Manzanares M; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.; PhD Program in Biomedical Sciences and Public Health, Universidad Nacional de Educación a Distancia (UNED), Madrid, Spain., Ramos-Martín F; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain., Rodríguez-Mora S; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.; Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Casado-Fernández G; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.; Faculty of Sciences, Universidad de Alcalá, Madrid, Spain., Sánchez-Menéndez C; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.; PhD Program in Biomedical Sciences and Public Health, Universidad Nacional de Educación a Distancia (UNED), Madrid, Spain.; Hematology and Hemotherapy Service, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Hospital Universitario Ramón y Cajal, Madrid, Spain., Simón-Rueda A; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.; PhD Program in Biomedical Sciences and Public Health, Universidad Nacional de Educación a Distancia (UNED), Madrid, Spain., Mateos E; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.; Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Cervero M; Internal Medicine Service, Hospital Universitario Severo Ochoa, Madrid, Spain.; School of Medicine, Universidad Alfonso X El Sabio, Madrid, Spain., Spivak AM; Division of Microbiology and Immunology, Department of Pathology, University of Utah School of Medicine, Salt LakeCity, UT, United States., Planelles V; Division of Microbiology and Immunology, Department of Pathology, University of Utah School of Medicine, Salt LakeCity, UT, United States., Torres M; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.; Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., García-Gutiérrez V; Hematology and Hemotherapy Service, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Hospital Universitario Ramón y Cajal, Madrid, Spain., Coiras M; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.; Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2024 Sep 23; Vol. 15, pp. 1426974. Date of Electronic Publication: 2024 Sep 23 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39380908 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Sustained antiviral response against in vitro HIV-1 infection in peripheral blood mononuclear cells from people with chronic myeloid leukemia treated with ponatinib. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Manzanares+M%22">Manzanares M</searchLink>; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.; PhD Program in Biomedical Sciences and Public Health, Universidad Nacional de Educación a Distancia (UNED), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Ramos-Martín+F%22">Ramos-Martín F</searchLink>; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Mora+S%22">Rodríguez-Mora S</searchLink>; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.; Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Casado-Fernández+G%22">Casado-Fernández G</searchLink>; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.; Faculty of Sciences, Universidad de Alcalá, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Sánchez-Menéndez+C%22">Sánchez-Menéndez C</searchLink>; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.; PhD Program in Biomedical Sciences and Public Health, Universidad Nacional de Educación a Distancia (UNED), Madrid, Spain.; Hematology and Hemotherapy Service, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Hospital Universitario Ramón y Cajal, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Simón-Rueda+A%22">Simón-Rueda A</searchLink>; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.; PhD Program in Biomedical Sciences and Public Health, Universidad Nacional de Educación a Distancia (UNED), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Mateos+E%22">Mateos E</searchLink>; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.; Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Cervero+M%22">Cervero M</searchLink>; Internal Medicine Service, Hospital Universitario Severo Ochoa, Madrid, Spain.; School of Medicine, Universidad Alfonso X El Sabio, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Spivak+AM%22">Spivak AM</searchLink>; Division of Microbiology and Immunology, Department of Pathology, University of Utah School of Medicine, Salt LakeCity, UT, United States.<br /><searchLink fieldCode="AU" term="%22Planelles+V%22">Planelles V</searchLink>; Division of Microbiology and Immunology, Department of Pathology, University of Utah School of Medicine, Salt LakeCity, UT, United States.<br /><searchLink fieldCode="AU" term="%22Torres+M%22">Torres M</searchLink>; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.; Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22García-Gutiérrez+V%22">García-Gutiérrez V</searchLink>; Hematology and Hemotherapy Service, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Hospital Universitario Ramón y Cajal, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Coiras+M%22">Coiras M</searchLink>; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.; Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2024 Sep 23; Vol. 15, pp. 1426974. <i>Date of Electronic Publication: </i>2024 Sep 23 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39380908 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fphar.2024.1426974 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1426974 Titles: – TitleFull: Sustained antiviral response against in vitro HIV-1 infection in peripheral blood mononuclear cells from people with chronic myeloid leukemia treated with ponatinib. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Manzanares M – PersonEntity: Name: NameFull: Ramos-Martín F – PersonEntity: Name: NameFull: Rodríguez-Mora S – PersonEntity: Name: NameFull: Casado-Fernández G – PersonEntity: Name: NameFull: Sánchez-Menéndez C – PersonEntity: Name: NameFull: Simón-Rueda A – PersonEntity: Name: NameFull: Mateos E – PersonEntity: Name: NameFull: Cervero M – PersonEntity: Name: NameFull: Spivak AM – PersonEntity: Name: NameFull: Planelles V – PersonEntity: Name: NameFull: Torres M – PersonEntity: Name: NameFull: García-Gutiérrez V – PersonEntity: Name: NameFull: Coiras M IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 09 Text: 2024 Sep 23 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 1663-9812 Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in pharmacology Type: main |
| ResultId | 1 |